摘要
目的探讨组织中植入^(125)I粒子治疗进展期贲门-胃底癌、胃癌的临床疗效。方法对24例贲门-胃底癌、胃癌患者采用内镜下植入^(125)I粒子。植入两个月后评价疗效,随访。结果植入^(125)I粒子两个月后,23例自觉症状基本消失,经2年随诊9例死亡,15例存活。结论^(125)I粒子组织内植入治疗进展期贲门-胃底癌、胃癌疗效较好,不良反应轻微。
Objective To investigate the efficacy of radioactive125I particles implantation in the treatment of advanced gastric cardia cancer and gastric cancer. Methods We collected 24 cases of gastric cardia cancer,fundus of stomach cancer and gastric cancer. Results125I particles were implanted via endoscope. All patients were followed and evaluated for 2 years. After the implantation125I particles for Two months after125I particles implantation,23 patients＇ symptoms disappeared. After following up for 2 years,there were 9 deaths and 15 cases of survival. Conclusion125I particles implantation in the treatment of advanced gastriccardia cancer,fundus of stomach cancer and gastric cancer seems to be effective and adverse reaction is minor.
出处
《标记免疫分析与临床》
CAS
2016年第11期1317-1320,共4页
Labeled Immunoassays and Clinical Medicine
关键词
125I粒子
组织内植入
贲门—胃底癌、胃癌
内镜
125I particles
Tissue implantation
Cardia gastric fundus carcinoma Gastric cancer
Endoscopy
